Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia.

Source:http://linkedlifedata.com/resource/pubmed/id/19487933

Download in:

View as

General Info

PMID
19487933